Fundz

Aridis Pharmaceuticals Receives Funding To Evaluate Inhaled Monoclonal Antibodies To Block Influenza And Sars-Cov-2 Transmission

PRIVATEJan 27, 2022

Round Type

Funding Round

Los GatosHealthcare

Description

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, received a grant award from the Bill & Melinda Gates Foundation ('Gates Foundation') to evaluate the application of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies (mAbs) against influenza and SARS-CoV2 to people in low- and middle-income countries.

Quick answer

Aridis Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round, dated January 27, 2022. Aridis Pharmaceuticals, Inc. is based in Los Gatos, California, United States.

How much did Aridis Pharmaceuticals, Inc. raise?
Aridis Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round on January 27, 2022.
What does Aridis Pharmaceuticals, Inc. do?
Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections.
Where is Aridis Pharmaceuticals, Inc. based and how big is it?
Aridis Pharmaceuticals, Inc. is based in Los Gatos, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Aridis Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CardioWise, Inc. raised $300K (Seed) on March 11, 2022.
  • Seriously Clean LTD raised an undisclosed amount on March 11, 2022.
  • Avive Solutions, Inc. raised $57M on March 11, 2022.
  • Dragonfly Therapeutics, Inc. raised $13M on March 11, 2022.
  • Vascarta Inc. raised $50K (Seed) on March 11, 2022.
  • RefleXion Medical raised $80M (Funding Round) on March 10, 2022.

Who to call at Aridis Pharmaceuticals, Inc., and when

A new round usually means Aridis Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aridis Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aridis Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aridis Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aridis Pharmaceuticals, Inc.

Location

983 UNIVERSITY AVENUE

Los Gatos, California, United States

About

Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aridis Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aridis Pharmaceuticals, Inc.'s next move

See what Strategic adds

Aridis Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.